25 May 2013
Keywords: amgen, initiates, ph, iii, aranesp, study, hf
Article | 18 August 2008
Biotechnology major Genzyme and fellow USA-based Isis Pharmaceuticals have begun a Phase III study of mipomersen in patients with
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 August 2008
1 September 2008
24 May 2013
© 2013 thepharmaletter.com